Pretax income is the income that a company earns before paying income taxes. Abiomed's pretax income for the
three
months ended in Sep. 2022 was $139 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2022 was $341 Mil.
Abiomed's pretax margin was 52.16%.
During the past 13 years, Abiomed's highest Pretax Margin was 34.23%. The lowest was 4.64%. And the median was 20.25%.
Abiomed Pre-Tax Income Historical Data
The historical data trend for Abiomed's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Abiomed's Pre-Tax Income
For the Medical Devices subindustry, Abiomed's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abiomed's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abiomed's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Abiomed's Pre-Tax Income falls into.
Abiomed Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Abiomed's Pretax Income for the fiscal year that ended in Mar. 2022 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $341 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abiomed (NAS:ABMD) Pre-Tax Income Explanation
Abiomed's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as
During the past 13 years, Abiomed's highest Pretax Margin was 34.23%. The lowest was 4.64%. And the median was 20.25%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abiomed Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Abiomed's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMD has been successfully added to your 